DLong MedTech Established in Tustin, California
July 25, 2024
DLong MedTech Inc. was established on July 25, 2024, in Tustin, California, with a mission to develop purpose-built, minimally invasive interventional devices for pulmonary and cardiovascular disease.
As a U.S.-based medical device company, DLong MedTech is focused on addressing unmet clinical needs through advanced balloon catheter technologies, drug-coated balloon platforms, and vascular simulation solutions. Its early development programs target chronic thromboembolic pulmonary hypertension, pulmonary artery stenosis, coronary small-vessel disease, and coronary bifurcation lesions.
DLong MedTech is building a foundation for product development, regulatory execution, quality system readiness, and future clinical translation, with a long-term vision to expand toward a broader pan-vascular technology platform.
